Lepalvir: Biomaterial efficacy and safety for patients with acute ischemic stroke.

iScience · 2025 · PMC11804740 · PMID 39925427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

However, the high-dose Lepalvir group exhibited a slight trend toward superior effectiveness compared to the control group.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.